Submitted by Anonymous (not verified) on 13 June 2025 - 14:50
Human medicines European public assessment report (EPAR): Rivastigmine Actavis, rivastigmine, Date of authorisation: 16/06/2011, Revision: 21, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rivastigmine Actavis, rivastigmine, Date of authorisation: 16/06/2011, Revision: 21, Status: Authorised